Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta ...
Manchester’s hospitals have slashed carbon emissions and saved millions by tackling a decades-old hidden problem. Helena Vesty reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results